Researcher
Hans Wildiers
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Projects
1 - 10 of 27
- Breast cancer projectFrom1 Jan 2024 → TodayFunding: Other federal public and semi-governmental institutions
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Building a large blood biobank of patients with new breast cancer diagnosis for future researchFrom1 Jan 2022 → 5 Jun 2023Funding: Other federal public and semi-governmental institutions
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- The impact of coaching on quality of life of older cancer patientsFrom27 Sep 2021 → 31 Aug 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patientsFrom1 Apr 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Mechanisms involved in metastasis of luminal breast cancerFrom1 Mar 2021 → 28 Feb 2022Funding: Foundations, funds and other with scientific goal
- The MBC biobank collection.From1 Dec 2020 → 31 Oct 2021Funding: Other federal public and semi-governmental institutions
- Risk prediction and modeling of cancer therapy related cardiotoxicityFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Novel biomarkers in the risk stratification, surveillance and treatment of young breast cancer patients and germline carriers of pathogenic variants in TP53.From1 Sep 2020 → 13 Feb 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 475
- A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry(2023)
Authors: Thaïs Baert, Diether Lambrechts, Ann Smeets, Hans Wildiers
- Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival(2023)
Authors: Diether Lambrechts, Ines Nevelsteen, Patrick Neven, Hans Wildiers
Pages: 16142 - 16162 - Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk(2023)
Authors: Sigrid Hatse, Diether Lambrechts, Hans Wildiers
- Obesity-associated changes in molecular biology of primary breast cancer(2023)
Authors: Ha Linh Nguyen, Tatjana Geukens, Maxim De Schepper, Stefan Naulaerts, Ines Nevelsteen, Patrick Neven, Karen Van Baelen, Hanne Vos, Hans Wildiers, Beppe Floris, et al.
- Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer(2023)
Authors: Tatjana Geukens, Maxim De Schepper, François Richard, Karen Van Baelen, Ha Linh Nguyen, Sophia Leduc, Anirudh Pabba, Gitte Zels, Ann Smeets, Ines Nevelsteen, et al.
Pages: 152 - 160 - Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium(2023)
Authors: Victoria Depoorter, Koen Milisen, Johan Flamaing, Cindy Kenis, Hans Wildiers
Pages: 1 - 11 - EXPLORING AGEING-RELATED BIOMARKERS IN INDIVIDUALS WITH BREAST CANCER AND WITHOUT CANCER(2023)
Authors: Qi Wu, Hans Wildiers, Sarah-Maria Fendt, Sigrid Hatse
- End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data Linkage(2023)
Authors: Victoria Depoorter, Koen Milisen, Johan Flamaing, Cindy Kenis, Hans Wildiers
- Relation between circulating biomarkers at diagnosis of early luminal-like breast cancer and subsequent risk of distant metastases.(2023)
Authors: Yentl Lambrechts, Beppe Floris, Patrick Neven, Ines Nevelsteen, François Richard, Christine Desmedt, Hans Wildiers, Sigrid Hatse
- The Upgrade Risk of B3 Lesions to (Pre)Invasive Breast Cancer After Diagnosis on Core Needle or Vacuum Assisted Biopsy. A Belgian National Cohort Study(2023)
Authors: Patrick Neven, Beppe Floris, Eva Oldenburger, Sileny Han, Chantal Van Ongeval, Ann Smeets, Hans Wildiers, Nele Laudus, Els Dequeker
Pages: E273 - E280